Introduction {#s1}
============

Like most DNA viruses, the genome of Herpes simplex virus-1 (HSV-1) is transcribed by RNA Polymerase II (Pol II) ([@bib3]). Its approximately 85 genes ([@bib37]; [@bib36]; [@bib35]) are transcribed in a temporally coordinated sequence, such that their protein products are expressed at the appropriate time in the life cycle of the virus ([@bib24]; [@bib25]; [@bib26]). Immediate early (IE) gene products enable the efficient expression of early (E) and late (L) genes. The protein products of E genes are mostly involved in DNA replication. DNA replication and IE proteins enable the efficient transcription of L genes, which encode the structural components of the virus. DNA replication licenses L promoters, enabling the binding of core Pol II transcription factors, thus activating the initiation of L transcription ([@bib19]). This entire transcriptional cascade is observed within 3 hour (h) post entry ([@bib16]; [@bib19]), culminating in production of the first viral progeny between 4 and 6 h post-infection (hpi). To accomplish this robust and rapidly changing program of transcription, the viral genome must compete with the vastly larger cellular genome for numerous Pol II transcription factors, in addition to mediating the possible constraints of cellular histones.

A major component of this cascade is the IE protein Infected Cell Polypeptide 4 (ICP4) ([@bib12]). ICP4 is essential for viral growth because it promotes efficient transcription of viral E and L genes ([@bib18]; [@bib40]; [@bib51]). Thus, in the absence of ICP4, E and L proteins are poorly expressed, IE proteins are overproduced, DNA replication does not occur, and there is no detectable viral yield ([@bib13]). ICP4 was first shown to bind to DNA cellulose made from salmon sperm DNA ([@bib39]). [@bib21] later showed ICP4 has sequence-specific DNA binding activity. ICP4 interacts with a number of cellular general transcription factors (GTFs), predominantly components of TFIID and the Mediator complex ([@bib9]; [@bib32]; [@bib50]), facilitating their recruitment to the viral genome through its DNA binding activity ([@bib16]; [@bib32]; [@bib45]). ICP4 is synthesized early in infection, binds to the viral genome located at ND10 structures ([@bib20]), and remains associated with the genome throughout all phases of infection ([@bib16]). Therefore, ICP4 has the potential to influence events occurring on the viral genome from a time when genome number is at a minimum, and ICP4 expression is peaking, through a time when genome numbers are greatly elevated by replication.

Studies have also shown that epigenetic modulation of histones associated with the viral genome early in infection can affect productive viral infection ([@bib28]; [@bib34]). However, we have shown that the abundance of histones is relatively low or absent, and that ICP4 is one of the most abundant proteins on viral genomes during productive infection ([@bib15]). In this study, we set out to determine the relationship between ICP4 and histones binding to the viral and cellular genomes, and the consequences for viral and cellular transcription. We propose that ICP4 is a major component of viral nucleoprotein, which functions in place of traditional cellular chromatin, and allows for the robust recruitment of cellular transcription factors specifically to the viral genome.

Results {#s2}
=======

ICP4 binding is altered by viral genome replication {#s2-1}
---------------------------------------------------

Given the central role of ICP4 in viral gene transcription at all stages of infection, we were interested in how ICP4 interacts with the virus genome as the number exponentially increases, as a consequence of replication. We infected human fibroblast (MRC5) cells with wild-type HSV-1 (KOS) for two, four, and six hpi and performed ChIP-Seq for ICP4. Each time point represents a different replication state: two hpi (prereplication), four hpi (3--4 genome duplications), six hpi (5--6 genome duplications) ([Figure 1A](#fig1){ref-type="fig"}). To quantitatively compare samples, we had to account for viral genome replication. Input samples provided the relative number of viral genomes present at each time point. We used this ratio to normalize immunoprecipitated (IP) sample for the amount of factor per genome. Early during infection (two hpi) ICP4 densely coated the viral genome ([Figure 1B--C](#fig1){ref-type="fig"}). Viral genome replication decreased the amount of ICP4 bound per genome ([Figure 1A--B](#fig1){ref-type="fig"}) resulting in a pattern containing sharper peaks. By six hpi ICP4 binding was retained exclusively on strong ICP4 binding motifs ([Figure 1C](#fig1){ref-type="fig"}). Some of the retained binding sites were those previously established as having an inhibitory effect on the gene promoter bound, including ORF P, ICP4, and LAT ([Figure 1D](#fig1){ref-type="fig"}). A closer analysis of ICP4 peaks demonstrated that the location and number of high confidence occupied sites did not alter significantly throughout infection ([Figure 1E](#fig1){ref-type="fig"}). Instead the amount of ICP4 bound between distinct peaks decreased as genome number increased ([Figure 1C--D](#fig1){ref-type="fig"}).

![ICP4 binding at key points in the viral life cycle.\
MRC5 cells were infected with HSV-1 for 2, 4, or 6 h, and ChIP-Seq for ICP4 was performed. (**A**) Quantification of viral genomes, measured as Input sample viral mapped reads (MR), normalized for sequencing depth or Total Reads (TR). Samples were normalized to two hpi, which was set as 1. (**B**) Quantification of ICP4 binding per viral genome measured as viral MR from ICP4 immunoprecipitation (IP) per viral MR from Input. (**C--D**) All data was normalized for sequencing depth and viral genome number using input ChIP-Seq reads. Viral ORFs are indicated, color coded by gene class with IE as yellow, E as green, leaky late (L1) as blue, and true late (L2) as purple. Find Individual Motif Occurrences (FIMO) identified genome sequences matching the consensus motif in B are indicated in red. (**E**) Intersection of MACS2 identified ICP4 occupied regions. (**F**) ICP4 consensus binding motif.](elife-51109-fig1){#fig1}

Although ICP4 exhibited a dense binding pattern at early times (two hpi), with relatively broad, overlapping peaks we were able to determine high confidence binding sites. The final sites were consistent between biological replicates. We analyzed 100 bp extensions from the summits of the peaks seen at all three times ([Figure 1E](#fig1){ref-type="fig"}) for motif discovery. DTSGKBDTBNHSG was the only motif discovered ([Figure 1F](#fig1){ref-type="fig"}), where D is A, G, T; S is C or G; K is G or T; B is C, G, T; H is A, C, T. This binding motif is similar to that previously discovered using in vitro techniques, RTCGTCNNYNYSG ([@bib17]).

These results demonstrate that ICP4 binds to specific sites, but also coats the genome early in infection forming a type of nucleoprotein. Due to mass action, ICP4-nucleoprotein changes as infection proceeds, limiting binding to predominantly strong cognate binding sites as the number of genomes increase due to replication.

ICP4 stabilizes GTF binding promoting cooperative preinitiation complex (PIC) assembly {#s2-2}
--------------------------------------------------------------------------------------

We wanted to investigate how the formation of ICP4-nucleoprotein affects the transcription factor landscape across the viral genome. We compared the binding of ICP4, Pol II, TATA-binding protein (TBP), SP1, Med1, and Med23 in ICP4 null (n12) and wild-type (WT) HSV-1 infected human fibroblasts at 2.5 hpi by ChIP-Seq ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). In all Pol II IP's we used an antibody which preferentially binds to phospho S5 of the C-terminal domain repeat region. This post-translational modification is associated with Pol II found on mRNA promoters and splice sites.

In n12 infection, we observed a decrease in binding for all the factors to most viral promoters, with the exception of IE genes ([Figure 2A--B](#fig2){ref-type="fig"}), where there was an increase in binding. There were detectable, although highly reduced, peaks of TBP and SP1 binding to the UL23 promoter in the absence of ICP4. It has been previously shown that these sites are functional in the n12 background reflecting the basal binding activity of TBP and SP1 ([@bib27]) ([Figure 2B](#fig2){ref-type="fig"}). Similar to UL23 we observed TBP and SP1 bound to selective E promoters in the absence of ICP4, namely UL23, UL29, UL39, and UL50 ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}).

![ICP4 recruitment of host Pol II machinery to viral promoters.\
MRC5 cells were infected with an ICP4 null mutant (n12) or HSV-1 (WT) for 2.5 h and ChIP-Seq for ICP4, Pol II, TBP, Sp1, Med1, and Med23 was performed. All data was normalized for sequencing depth and viral genome number using input ChIP-Seq reads. Viral ORFs are indicated, color coded by gene class with IE as yellow, E as green, leaky late (L1) as blue, and true late (L2) as purple. (**A**) Fold change of n12 over WT aligned to the viral genome. Loci with greater binding in n12 or WT are colored in green or red, respectively. (**B**) ChIP-Seq reads normalized per viral genome and aligned to canonical IE, E, and L1 genes.](elife-51109-fig2){#fig2}

There were a relatively small number of reads in the ICP4 ChIP of n12 ([Figure 2A](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). As ICP4 is an essential viral protein, we prepared stocks of n12 in an ICP4 complementing cell line. ICP4 is packaged into the tegument of virions ([@bib52]), which results in packaging of wild type ICP4 into n12 virions ([@bib16]). The reads in the ICP4 ChIP of n12 are most likely due to ICP4 packaged in the virion. While the ultimate source of these reads is not clear at present, the amount of binding of ICP4 from the virion to DNA is not sufficient to promote transcription complexes on viral early and late genes.

Med1 and Med23 bound the viral genome with an almost identical pattern ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}, [Figure 2](#fig2){ref-type="fig"}), indicating they are parts of the Mediator complex bound early during viral infection. In WT infected cells, the binding of Mediator concentrated near the starts sites of ICP4-induced viral genes. However, the Mediator complex also densely coated the viral genome, resembling the ICP4 binding pattern. This dense coating was completely absent in n12 infection, demonstrating this phenotype is not an artifact of the IP. We suspect this reflects the fact that ICP4 and Mediator interact.

In the absence of ICP4, the binding of Pol II was reduced the most compared to the other transcription factors ([Figure 2A](#fig2){ref-type="fig"}). This magnified difference is likely a result of the cooperative nature of Pol II recruitment requiring multiple protein-protein interactions. In summary ICP4 was required for robust recruitment of all GTF's tested, cooperatively recruiting Pol II to E and L promoters ([Figure 2B](#fig2){ref-type="fig"}). The difference between n12 and WT shows the extent by which ICP4 mediated recruitment and bolstered the frequency of PIC assembly. IE promoters retained robust GTF recruitment via an independent mechanism involving a complex consisting of Oct-1, HCF and VP16 binding to TAATGARAT promoter elements ([@bib41]; [@bib49]; [@bib48]).

Genome-bound ICP4 does not affect accessibility {#s2-3}
-----------------------------------------------

Part of the mechanism of ICP4 action in the recruitment of GTFs to the genome may involve a role in the exclusion of repressive chromatin. To address this hypothesis, we investigated the relationship between presence of ICP4, the abundance of histones, and the accessibility of the genome. We used ChIP-Seq to compare the binding of ICP4, Pol II, and histone H3 in n12 and WT HSV-1 infected human fibroblasts at two hpi ([Figure 3](#fig3){ref-type="fig"}). We found in both WT and n12 infection that the number of H3 reads mapped to the viral genome was 100-fold less than ICP4, and the pattern was nearly identical to input reads ([Figure 3A](#fig3){ref-type="fig"}), with R^2^ correlations of 0.0004 and 0.02 ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). These data demonstrated H3 binding to the viral genome was minimal and not reproducible. Furthermore, H3 binding was still minimal in the absence of ICP4 (n12). This was not due to technical issues as the number and quality of H3 reads mapped to the cellular genome for the same samples was approximately 10 million with R^2^ correlations of ≥0.97 ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). We saw a similar trend with H3K4me3, H3K27ac, H3K9me3, and H3K27me3 reads mapped to the viral genome ([Figure 3---figure supplements 1](#fig3s1){ref-type="fig"}--[3](#fig3s3){ref-type="fig"}).

![ICP4 dependence of viral genome accessibility and Histone H3 binding.\
MRC5 cells were infected with an ICP4 null mutant (n12) or HSV-1 (WT) and harvested prior to genome replication. (**A**) ChIP-Seq for ICP4, Pol II, H3 and B--D) ATAC-Seq was performed. All data was normalized for sequencing depth and viral genome number using input ChIP-Seq reads. (**C**) Quantitative analysis of ATAC-Seq data, measuring the relative tagmentation enrichment for the virus or host as compared to expected. (**D**) Histogram plot of ATAC-Seq fragment size for reads mapped to the viral (red) or cellular (black) genome. Mononucleosome protected fragments are approximately 180--250 bp.](elife-51109-fig3){#fig3}

Although H3 binding to the viral genome was similar in WT and n12 infection, we could not rule out the role of an alternative protein occluding the genome. To investigate genomic accessibility, we performed ATAC-Seq. Human fibroblasts were infected with WT and n12 HSV-1 at an MOI of 10 pfu/cell and collected prior to the onset of genome replication. Quantification of ChIP-Seq input reads allowed us to determine that the approximate number of genomes per cell in WT and n12 infection was 169 and 254, respectively ([Figure 3C](#fig3){ref-type="fig"}). This value is consistent with infecting at an MOI of 10 pfu/cell and an approximately particle to pfu ratio of 20--30. We normalized ATAC-Seq traces to adjust for sequencing depth and input genome number. We observed even tagmentation in both conditions ([Figure 3B](#fig3){ref-type="fig"}) absent the nucleosomal laddering visible on the cellular genome ([Figure 3D](#fig3){ref-type="fig"}). Quantification of ATAC-Seq reads determined that the viral genome in n12 and WT was 2.2 and 2-fold more accessible than the cellular genome ([Figure 3C](#fig3){ref-type="fig"}). As we harvested samples pre-replication, we expect that a significant portion of viral genomes are defective and will not undergo replication. Our ATAC-Seq data is thus an average of tagmentation for defective and active viral genomes. For this reason, we expect our accessibility calculation is an underestimate. We conclude that the viral genome was much more accessible than the cellular genome, and this increased accessibility was not ICP4-dependent. ICP4 binding and GTF recruitment, not viral genome accessibility, was responsible for robust GTF binding.

ICP4 binds to cellular transcription start sites (TSS) early during infection {#s2-4}
-----------------------------------------------------------------------------

Immunofluorescence (IF) studies of HSV-1 infection depict colocalization of ICP4 with EdC-labeled viral genomes and exclusion from dense areas of cellular chromatin ([@bib15]). This phenomenon is so well established that ICP4 is largely used in IF studies as a proxy for HSV-1 genomes. To ascertain if ICP4 also binds to the cellular genome, we aligned our ICP4 ChIP-Seq data from 2, 4, and six hpi to the cellular genome. ICP4 bound to the cellular genome in a manner quite distinctive from the pattern observed on the viral genome. ICP4 only bound in distinct peaks around cellular transcription start sites (TSS) of a subset of cellular genes ([Figure 4A--D](#fig4){ref-type="fig"}). These genes grouped ontologically to common housekeeping functions including pathways related to chromatin, transcription, and metabolism ([Figure 4F](#fig4){ref-type="fig"}). This binding reduced from 2 to 4 hpi, and became negligible at six hpi ([Figure 4A--B](#fig4){ref-type="fig"}). At two hpi ICP4 bound to the cellular genome at 5727 sites ([Figure 4E](#fig4){ref-type="fig"}) or 0.002 peaks per kbp, whereas ICP4 bound to the viral genome at 122 sites ([Figure 1E](#fig1){ref-type="fig"}) or 0.8 peaks per kbp. Similar we found a much greater density of ICP4 binding motifs present in the viral genome (two motifs/kbp) than the cellular genome (0.02 motifs/kbp). We observed ICP4 binding peaks that did not localize at an ICP4 binding consensus ([Figure 4A](#fig4){ref-type="fig"}) suggesting that ICP4 may associate with the cellular genome by an alternative mechanism. We conclude that ICP4 bound to the cellular genome early during infection, when the relative concentration of ICP4 to viral genomes is still quite high. The amount of ICP4 on the cellular genome quickly dropped off as viral genome number increased and ICP4 preferentially bound to the viral genome.

![ICP4 binds cellular promoters during early infection.\
MRC5 cells were infected with HSV-1 for 2, 4, or 6 h, and ChIP-Seq for ICP4 was performed. Data was aligned to the human genome (hg38) and normalized for cellular genome sampling. (**A**) Representative region of the cellular genome. ICP4 binding motifs are indicated in red. (**B, D**) Sequencing data centered + /- 1 kilobase from the transcription start site (TSS) of cellular mRNAs. (**C**) Sequencing data scaled from mRNA TSS to the transcription end site (TES). (**E**) Intersection of MACS2 identified ICP4 occupied regions. (**F**) Top 10 enriched Reactome groups for genes (n = 2190) with ICP4 bound at the promoter at 2 hr.](elife-51109-fig4){#fig4}

ICP4 binding is restricted to accessible regions of the cellular genome {#s2-5}
-----------------------------------------------------------------------

Since ICP4 bound to a subset of cellular genes near mRNA start sites ([Figure 4](#fig4){ref-type="fig"}), We hypothesized that ICP4 only bound to accessible regions of the cellular genome. To test this hypothesis, we performed ChIP-Seq for ICP4, Pol II, Histone H3 (H3), euchromatic markers H3K4-trimethyl (H3K4me3) and H3K27-acetyl (H3K27ac), and heterochromatic marker H3K9-trimethyl (H3K9me3) and H3K27-trimethyl (H3K27me3) on MRC5 cells that were infected with HSV for 2 hr. Cellular TSS were stratified using k-means clustering as high and low ICP4 binding ([Figure 5A](#fig5){ref-type="fig"}). TSS with high ICP4 binding were also bound by Pol II and adjacent to euchromatic markers. TSS with low ICP4 binding were associated with only heterochromatic markers. Furthermore, genes clustered as high ICP4 binding had higher tagmentation frequency when assessed using ATAC-Seq ([Figure 5B](#fig5){ref-type="fig"}). The data was mapped for representative cellular genes in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. We quantified the relationship between ICP4 and cellular chromatin in [Figure 5C--D](#fig5){ref-type="fig"}. We found that the binding pattern of ICP4 was directly related (Spearman coefficient ≥0.5) to Pol II and cellular euchromatin, clustering as most similar to H3K27ac and H3K4me3 ([Figure 5C](#fig5){ref-type="fig"}). The heterochromatic markers, H3K9me3 and H3K27me3, clustered together, and were not correlated (Spearman coefficient \~0) to ICP4 or cellular chromatin. These results were corroborated by analysis of distinct peaks called using MACS ([Figure 5D](#fig5){ref-type="fig"}). Interestingly, ICP4 bound regions had little overlap with their cognate binding motifs ([Figure 5D](#fig5){ref-type="fig"}). A closer analysis of the actual genomic region where each factor bound, revealed that 82% of ICP4 bound regions were within 1 kb of a promoter ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). By comparison only 10% of ICP4 predicted binding motifs were within 1 kb of a promoter. Furthermore, the euchromatic regions of the cellular genome that were occupied by ICP4 in infected cells were also euchromatic in uninfected cells, indicating that ICP4 does not globally promote open chromatin in these regions of the genome ([Figure 5A--B](#fig5){ref-type="fig"}). These data support a model in which ICP4 is able to bind nonspecifically to accessible regions of the cellular genome, namely active promoters, early in infection when the relative concentration of ICP4 is high.

![Association between cellular ICP4 binding and chromatin.\
MRC5 cells were uninfected or infected with HSV-1 for 2 h. All data was aligned to the human genome (hg38) and normalized for sequencing depth. (**A, C--D**) ChIP-Seq data for ICP4, Pol II, H3, H3K4me3, H3K27acetyl, H3K9me3, and H3K27me3. (**B**) ATAC-Seq data. (**A--B**) Sequencing data centered + /- 1 kilobase from the TSS of cellular mRNAs. Data was stratified for ICP4 binding using K-means clustering. (**C**) Spearman correlation analysis, limited to cellular transcripts. (**D**) Intersection of MACS2 peaks, analyzed as number of intersecting peaks or Jaccard statistic.](elife-51109-fig5){#fig5}

ICP4 mediates depletion of pol II on cellular promoters {#s2-6}
-------------------------------------------------------

We observed depletion in Pol II binding to cellular promoters with infection ([Figure 5A](#fig5){ref-type="fig"}). This observation is consistent with prior studies, which assessed HSV-1 infection post-replication at three, four, or six hpi ([@bib1]; [@bib6]; [@bib38]). As we harvested samples prior to the onset of genome replication (two hpi) we hypothesized that ICP4, which is produced immediately upon viral infection was responsible. First, we determined the effect of ICP4 on cellular promoters before the onset of genome replication. We mock-infected or infected fibroblasts at 10 pfu/cell with WT or ICP4-null (n12) HSV-1 for 2 h. We observed depletion of Pol II occupancy on cellular mRNA promoters only in WT infection ([Figure 6A--B](#fig6){ref-type="fig"}). Thus we concluded that ICP4 was required for depletion of Pol II from host mRNA promoters, and this effect was independent of viral genome copy number.

![The role of ICP4 in Pol II loss on host promoters.\
MRC5 cells were (**A-B**) uninfected or infected with n12 or WT HSV-1 and harvested prior to genome replication or C-D) infected with tsKos and grown at permissive conditions (P), shifted up from permissive to nonopermissive conditions at four hpi (S), or nonpermissive conditions (N). (**A--D**) ChIP-Seq for Pol II was performed. Data was aligned to the human genome (hg38) and normalized for cellular genome sampling. ChIP-Seq data was aligned to cellular promoters + /- 1 kilobase from TSS. The average signal for each condition plotted as a line graph.](elife-51109-fig6){#fig6}

We then assessed whether ICP4 was continuously required for cellular Pol II depletion, namely if ICP4 was still essential even after the onset of genome replication. We used a temperature sensitive ICP4 mutant (tsKos), in which growth at nonpermissive temperature (39.6°C) results in loss of ICP4 in the nucleus ([@bib19]). We infected fibroblasts with tsKos grown at permissive conditions (P), shifted up from permissive to nonpermissive conditions at four hpi (S), or nonpermissive conditions (N). In this system we can separate the role of ICP4 in Pol II depletion, from ICP4's requirement in E and L transcription and viral genome replication. Infected cells were harvested at four or six hpi and Pol II ChIP-Seq was performed. We used nonpermissive conditions as a surrogate to mock-infection, as we just established that Pol II depletion does not occur in n12 infection ([Figure 6A--B](#fig6){ref-type="fig"}). We observed significant depletion of Pol II from cellular promoters in permissive and shifted samples ([Figure 6C--D](#fig6){ref-type="fig"}). Pol II depletion was not directly related to viral genome copy number. tsKos shifted up had the highest number of viral genomes present, but did not reach the same level of cellular Pol II depletion as cells grown at permissive temperature for the same length of time. These data suggest that the viral genome is not solely responsible for preferential recruitment of cellular Pol II. Instead ICP4 bound to the viral genome is required for depletion of Pol II from cellular promoters. These results suggest a model in which genome replication facilitates host Pol II depletion when the relative number of ICP4 to viral genomes is high (2 hpi). As the number of ICP4 bound viral genomes increased, we observed a corresponding decrease in Pol II on host promoters.

Discussion {#s3}
==========

ICP4 as a sink for general transcription factors {#s3-1}
------------------------------------------------

ICP4 is synthesized shortly after the viral genome enters the nucleus and remains associated with the genome through all phases of infection. Our data demonstrated that ICP4 bound promiscuously to the viral genome prior to DNA replication. At this time point, the relative concentration of ICP4 to viral genomes was relatively high which likely promoted multimerization on DNA through ICP4-ICP4 interactions ([@bib30]). We observed a similar phenotype for ICP4's interaction partner, Mediator ([@bib32]; [@bib50]). Components of Mediator bound generally to the viral genome, concentrating near viral TATA boxes. Additional protein-Mediator interactions likely contribute to this distribution. This is a unique recruitment phenotype for Mediator which binds exclusively at cellular TSS via multiple protein-protein interactions. In the absence of ICP4, these interactions were not sufficient to support Mediator binding to the viral genome. With the exception of Mediator recruitment to IE promoters which does not require ICP4 and reflects the activity of VP16 ([@bib5]; [@bib8]). Similarly, we observed a 2 to 10-fold decrease in recruitment of Pol II, TBP, and Sp1 to viral E and L promoters without ICP4. This minimal level of recruitment is insufficient to support transcription, which explains why only IE transcripts are efficiently transcribed in the absence of ICP4.

ICP4-dependent GTF recruitment was not due to a global accessibility change. In the absence of ICP4 the viral genome remained absent of histones and had little change in tagmentation frequency. This is most likely due to the action of ICP0, which is an IE protein expressed in the absence of ICP4 and has been shown to preclude histones from the genome ([@bib10]; [@bib23]). We posit that ICP4's ability to interact and recruit Mediator and TFIID generally to the viral genome creates a local concentration gradient. Ultimately this increases the incidence of Pol II transcription machinery recruitment to the viral genome, which is stabilized by contact with additional protein-DNA, protein-protein interactions. Our observation that ICP4 coats the viral genome, a unique recruitment phenotype for a protein that functions in GTF recruitment likely reflects the architecture of the viral genome. The condensed organization of the HSV genome results in overlap of viral promoters and ORFS, with little to no unused coding space. For these reasons, it may be advantageous for ICP4 to generally and dynamically bind to the viral genome. It is also possible that the relatively high density of ICP4 on the viral genome prior to DNA replication may serve to repress transcription of the true late promoters, which only contain binding sites for the core GTFs. It has been shown that ICP4 binding can impose an increased dependence on DNA replication for expression from relatively simple promoters ([@bib29]; [@bib44]). These data demonstrated the critical role ICP4 serves as a general viral transcription factor, essential for activation and continued transcription of E and L genes.

ICP4 differentiates between the viral and cellular genome {#s3-2}
---------------------------------------------------------

ICP4 possesses the ability to bind to double stranded DNA independent of sequence, an ability that is facilitated by ICP4 oligomerization on the genome. At early time points, when the relative concentration of ICP4 to the viral genome was high, we observed promiscuous ICP4 binding. This coating phenotype provides an explanation for why no specific binding sites on the genome affect the ability of ICP4 to activate transcription ([@bib11]; [@bib46]). Instead the high density of ICP4 binding motifs on the viral genome aggregate to create a global affinity for ICP4.

Early during infection, we also observed binding of ICP4 to cellular promoters, a novel observation. ICP4 bound promoters of genes which grouped ontologically to common housekeeping functions including pathways related to chromatin, transcription, and metabolism. Furthermore, we found that ICP4 specifically bound where there was an absence of histones, adjacent to euchromatic markers. ICP4 did not alter the chromatic markers of the promoters it bound to, rather ICP4 bound regions which were also accessible in the absence of infection. This likely reflects ICP4's ability to bind naked double-stranded DNA in a sequence independent manner. This ability is promoted by ICP4 multimerization ([@bib30]), which is likely why we see the binding early during infection. The GTF's present on these cellular promoters, namely TFIID and Mediator complex, may further stabilize ICP4 binding at these promoters via their well-characterized interactions ([@bib9]; [@bib32]; [@bib50]).

The consequences, if any, of this binding for the transcription of specific cellular genes remains to be determined. The binding of ICP4 to the cellular genome was greatly diminished by four hpi, which corresponded to 3--4 viral genome duplications. At this time point we also observed a decrease in ICP4 coating the viral genome. However, ICP4 still bound abundantly, concentrating adjacent to strong cognate binding sites. This is most likely due to replication of the viral genome producing more ICP4 binding targets. Simple mass action results in binding to predominantly higher affinity sites. We propose that the binding preference of ICP4 for the viral genome is due to the 100-fold higher density of cognate binding sites and absence of cellular histones.

ICP4 as both viral transcription factor and chromatin {#s3-3}
-----------------------------------------------------

HSV-1 productive infection generates 1,000--10,000 viral progeny per infected cell within a 24 h window. To facilitate this rampant transcriptional shift HSV-1 manipulates host Pol II machinery to prioritize viral mRNAs. By six hpi viral mRNA's comprise almost 50% of the total mRNA present in the host nucleus ([@bib19]). Furthermore, binding of Pol II to cellular promoters dramatically decreases upon HSV-1 infection ([@bib1]; [@bib6]). A recent study concluded that viral replication compartments efficiently enrich Pol II into membraneless domains ([@bib38]). Herein we identified the viral factor responsible for coopting the host Pol II machinery.

McSwiggen et al. proposed this phenomenon was dependent on the absence of nucleosomes which made the viral genome 100-fold more accessible than the cellular genome. While we agree that this accessibility is critical for viral infection, we believe it is essential for ICP4 binding. Similar to cellular chromatin, ICP4 coats the viral genome throughout productive infection ([Figure 7](#fig7){ref-type="fig"}). However, ICP4 also functions to scaffold Pol II transcription machinery to the viral genome. We demonstrated that Pol II depletion from cellular promoters was dependent on the number of ICP4 bound viral genomes. We propose that one or more components of the PIC, such as the ICP4 binding partners TFIID and Mediator, are limiting and ICP4 recruits these factors to the viral genome. As the number of viral genomes bound by ICP4 increases, the limiting PIC components no longer contacts cellular promoters. Ultimately this results in decreased Pol II occupancy on host promoters, preventing cellular transcription. This mechanism is essential to facilitate the rapidly progressing infection while limiting the extent to which the host can respond to viral challenge.

![Model for ICP4 function.\
ICP4 preferentially binds to the more accessible viral genome recruiting cellular transcription factors preferentially to the viral genome, thus activating the virus and inhibiting cellular transcription.](elife-51109-fig7){#fig7}

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                          Designation                                                               Source or\            Identifiers                                                  Additional\
  (species) or\                                                                                                    reference                                                                          information
  resource                                                                                                                                                                                            
  -------------------------------------- ------------------------------------------------------------------------- --------------------- ------------------------------------------------------------ -----------------------------------
  Cell line (*Homo-sapiens*)             MRC5                                                                      ATCC                  ATCC CCL-171\                                                
                                                                                                                                         RRID:[CVCL_0440](https://scicrunch.org/resolver/CVCL_0440)   

  Cell line (*Cercopithecus aethiops)*   Vero                                                                      ATCC                  ATCC CCL-81\                                                 
                                                                                                                                         RRID:[CVCL_0059](https://scicrunch.org/resolver/CVCL_0059)   

  Cell line (*Cercopithecus aethiops)*   E5                                                                        [@bib14]              E5                                                           Vero cells stably expressing ICP4

  Strain, strain background\             KOS                                                                       [@bib47]                                                                           
  (*Human herpesvirus 1*)                                                                                                                                                                             

  Strain, strain background\             n12                                                                       [@bib14]              Strain KOS with nonsense mutation near ICP4 N-terminus       
  (*Human herpesvirus 1*)                                                                                                                                                                             

  Strain, strain background\             tsKos                                                                     [@bib19]              Strain KOS with temperature sensitive ICP4                   ICP4 has an A474V mutation
  (*Human herpesvirus 1*)                                                                                                                                                                             

  Antibody                               Anti-RNA polymerase II CTD repeat YSPTSPS (phospho S5) Mouse Monoclonal   Abcam                 Cat \#ab5408                                                 

  Antibody                               Anti-TATA binding protein\                                                Abcam                 Cat \#ab51841                                                
                                         Mouse Monoclonal                                                                                                                                             

  Antibody                               Anti-Sp1\                                                                 Santa Cruz            Cat \#sc-17824                                               
                                         Mouse Monoclonal                                                                                                                                             

  Antibody                               Anti-Human Sur-2 (Med23)\                                                 BD Pharmingen         Cat \#550429                                                 
                                         Mouse Monoclonal                                                                                                                                             

  Antibody                               Anti-Med1\                                                                Bethyl Laboratories   Cat \#A300-793A                                              
                                         Rabbit Polyclonal                                                                                                                                            

  Antibody                               Anti-Histone H3 (tri methyl K4) Mouse Monoclonal                          Abcam                 Cat \#ab12209                                                

  Antibody                               Anti-Histone H3 (tri methyl K27) antibody Mouse Monoclonal                Abcam                 Cat \#ab6002                                                 

  Antibody                               Anti-Histone H3 (acetyl K27) Rabbit Polyclonal                            Abcam                 Cat \#ab4729                                                 

  Antibody                               Recombinant Anti-Histone H3 (tri methyl K9) Rabbit Monoclonal             Abcam                 Cat \#ab176916                                               

  Antibody                               Anti-Histone H3 antibody Rabbit Polyclonal                                Abcam                 Cat \#ab1791                                                 

  Antibody                               Anti-ICP4 (58S) Mouse Monoclonal                                          Neal DeLuca           Hybridomas available from ATCC HB-8183                       
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Cells and viruses {#s4-1}
-----------------

Vero (African green monkey kidney) and MRC5 (human fetal lung) cells were obtained from and propagated as recommended by ATCC. Viruses used in this study include n12 ([@bib14]), tsKos ([@bib19]) and KOS ([@bib47]). n12 virus stocks were prepared and titered in a Vero-based ICP4 complementing cell line, E5. E5 cells were generated by stable transfection of Vero cells with ICP4 gene encoded on pK1-2 (GenBank Nucleotide JQ407535.1). E5 cells originate from a single colony, confirmed for its ability to complement the n12 virus and Western Blot assessed ICP4 expression ([@bib14]). KOS virus stocks were prepared and titered in Vero cells. tsKos virus stocks were prepared and tittered in Vero cells at permissive temperature (33.5°C). All cells are regularly tested for the presence of mycoplasma contamination. Cells used in this study were mycoplasma free.

Antibodies {#s4-2}
----------

The following antibodies were used: Pol II 4H8 specific to phospho S5 of the C-terminal domain repeat region (AbCam \#ab5408), TBP (AbCam \#ab51841), Sp1 (SantaCruz \#sc-17824), Med23 (BD Pharmingen \#550429), Med1 (Bethyl \#A300-793A), H3K4me3 (Abcam \#ab12209), H3K27me3 (AbCam \#ab6002), H3K27acetyl (AbCam \#ab4729), H3K9me3 (AbCam \#ab176916), H3 (AbCam \#1791), and ICP4 58S (derived from hybridomas-ATCC HB8183).

Viral infection {#s4-3}
---------------

MRC5 cells were infected with 10 PFU per cell. Virus was adsorbed in tricine-buffered saline (TBS) for 1 hr at room temperature. Viral inoculum was removed, and cells were washed quickly with TBS before adding 2% FBS media. Infected samples were incubated at 37°C unless otherwise specified.

ChIP-Sequencing {#s4-4}
---------------

Infected cells were treated with 5 mL of 25% formaldehyde for 15 min at room temperature, followed by 5 mL of 2.5 M glycine. All following steps were performed at 4°C unless otherwise stated. Cultures were washed with TBS and scraped into 50 mL of FLB \[5 mM 1,4-Piperazinediethanesulfonic acid (PIPES) pH 8, 85 mM KCl, 0.5% Igepal CA-630, 1x Roche protease inhibitor cocktail\]. Cells were pelleted by low-speed centrifugation, resuspended in 1.1 mL RIPA buffer \[1x phosphate-buffered saline (PBS), 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 1x Roche protease inhibitor cocktail\]. Sample was sonicated for 6 intervals of 30 s with a Sonics Vibra-Cell VCX 130 sonicator equipped with a 3 mm microprobe and pelleted at 2000 xg for 15 min. 50 µl was stored as an input control, and the remainder was divided equally to use in immunoprecipitations (IP). 2−4 × 10^7^ MRC5 cells were applied per IP. Samples were immunoprecipitated with 25 µg (TBP, Sp1), or 10 µg (Pol II, H3K4me3, H3K27me3, H3K27ac, H3K9me3, H3) antibody. Antibody was previously bound to 50 µL of Dynabeads M280 sheep anti-mouse IgG beads, or Dynabeads M280 sheep anti-rabbit IgG beads in 5% bovine serum albumin (BSA) 1x PBS overnight. DNA samples were bound to the antibody-bead complex overnight rotating. The IP mixtures were washed seven times with LiCl wash buffer \[100 mM Tris-HCl buffer pH 7.5, 500 mM LiCl, 1% Igepal CA-630, 1% sodium deoxycholate\] and once with Tris-EDTA (TE) buffer. Beads were resuspended in IP elution buffer \[1% SDS, 0.1M NaHCO~3~\] and incubated at 65°C for 2 hr 900 rpm. Input aliquot was suspended in IP elution buffer. Input and IP samples were incubated at 65°C 900 rpm overnight. The samples were extracted with phenol-chloroform-isoamyl alcohol (25:24:1) and with chloroform-isoamyl alcohol (24:1) and then purified using Qiagen PCR cleanup columns. Each sample was quantified using a Qubit 2.0 fluorometer (Invitrogen) and 2--20 ng was used to create sequencing libraries using the NEBNext Ultra II DNA Library preparation kit (NEB \#E7103S). Libraries were quantified using the Agilent DNA 7500 Kit, and samples were mixed together at equimolar concentration. Illumina HiSeq 2500 single-end 50 bp sequencing was carried out at the Tufts University Core Facility.

ATAC-Sequencing {#s4-5}
---------------

We adapted the protocol from [@bib7]. Briefly, 2 million MRC5 cells were plated into 60 mm dishes and allowed to grow overnight. Cells were infected as described above. Uninfected and n12 infected cells were harvested at four hpi. WT HSV-1 infected cells were harvested pre-replication at two hpi. Infected samples were washed once with chilled TBS and lysis-1 buffer \[10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl~2~\]. Samples were incubated with 2 mL lysis-2 buffer \[10 mM Tris-HCl pH 7.4, 10 mM NaCl, 3 mM MgCl~2~, 0.1% Igepal CA-630\] for 3 min on ice. Cells were gently resuspended and dounced until nuclei were visible via trypan blue staining. Nuclei were spun at 500 g for 10 min at 4°C and resuspended in lysis-1 buffer. 250 µL (5 × 10^5^ cells) was transferred to an epindorf tube and spun at 500 g for 10 min at 4°C. Nuclei were resuspended in 22 µL buffer TD (Illumina Catalog No. 15027866) 2.5 µL TDE1 (Illumina Catalog No. 15027865) and 22.5 µL water and incubated at 37°C for 30 min gently shaking. DNA was purified using the MinElute PCR purification kit (Qiagen Cat No./ID: 28004). PCR amplification was performed for 8--14 total cycles. Libraries were quantified using the Agilent DNA 7500 Kit, and samples were mixed together at equimolar concentration. Sequencing was carried out at the Tufts University Core Facility, Illumina HiSeq 2500 single-end 50 bp sequencing was carried out for replicate 1, Illumina Mid-Output NextSeq was carried out for replicates 2 and 3.

Data analysis {#s4-6}
-------------

### ChIP-Seq {#s4-6-1}

Data was uploaded to the Galaxy web platform, and we used the public server at [usegalaxy.org](http://usegalaxy.org) to analyze the data ([@bib2]). Data was first aligned using Bowtie2 ([@bib31]) to the human genome (hg38), and then unaligned reads were mapped to the HSV-1 strain KOS genome (KT899744.1). Bam files were visualized using DeepTools bamcoverage ([@bib43]) with a bin size of 1 to generate bigwig files. Data was viewed in IGV viewer and exported as EPS files. Bigwig files were normalized for sequencing depth and genome quantity. Mapped reads were multiplied by the 'norm factor' which was calculated as the inverse of $\left( Inputcellularreads \right)/\left( Inputcellular + viralmappedreads\left( TMR \right) \right) \times BillionsampleTMR$ or $\left( Inputviralreads \right)/TMR \times MillionsampleTMR$. ChIP-Seq experiments were repeated for a total of 2 to 4 biological replicates. The normalized bigwig files were averaged between replicates. Heatmaps and gene profiles were generated using MultiBigwigSummary ([@bib43]) on normalized cellular bigwig files to all UCSC annotated mRNAs. Gene profiles and heatmaps were plotted using plotProfile and plotHeatmap ([@bib43]). Spearman correlation analysis was performed using deeptools plotCorrelation on multiBigwigSummary limited to cellular transcripts ([@bib43]).

### Peak calling {#s4-6-2}

Viral peaks were called using MACS2 call peak ([@bib22]), pooling treatment and control files for each condition. Due to the small size of the viral genome (151974 bp) we could not use the shifting model option (\--nomodel). To offset the dense binding of ICP4 we used a fixed background lambda as local lambda for every peak region and a more sophisticated signal processing approach to find subpeak summits in each enriched peak region (\--call-summits).

Cellular peaks were called using MACS2 ([@bib22]). We first removed non-uniquely mapped sequences with SAMtools, filter SAM or BAM for a minimum MAPQ quality score of 20 ([@bib33]). We determined the approximate extension size for each IP using MACS2 predictd, and averaging the size estimate between replicates. We ran MACS2 call peak for individual replicates and pooled samples with no shifting model (\--nomodel). To determine high confidence peaks present in each MACS2 output we used Galaxy Operate on Genomic Intervals, Join. Peak intersection was analyzed for intersection size and jaccard statistic using JaccardBed ([@bib43]). ChIPseeker was run on MACS2 outputs to assess the cellular regions bound in each condition ([@bib53]).

### Motif discovery {#s4-6-3}

Bedtools Multiple Intersect ([@bib42]) was used to compare the MACS2 output for ICP4 IP at 2, 4, and 6 hr. A BED file was generated for regions + /- 100 bp from the summits of each identified peak. Peaks in common between all three experimental conditions were used to generate a fasta file using GetFastaBed ([@bib42]) Peaks present in all three time points were submitted to MEME v.4.11.1.0 for motif analysis ([@bib4]). The consensus sequence in [Figure 1](#fig1){ref-type="fig"} had the most significant E-value, and was the only motif found in more than five peaks.

### Correlation analysis {#s4-6-4}

To assess quality and reproducibility of data we assessed normalized bigwig files for each IP replicate. For cellular and viral alignments we ran MultiBigwigSummary ([@bib43]) with a bin size of 10,000 and 50 bp, respectively. Raw bin counts were plotted and a linear regression analysis was performed ([Figure 3---figure supplements 1](#fig3s1){ref-type="fig"}--[2](#fig3s2){ref-type="fig"}).

### ATAC-Seq {#s4-6-5}

Data was first aligned using Bowtie2 ([@bib31]) to the human genome (hg38), and then unaligned reads were mapped to the HSV-1 strain KOS genome (KT899744.1) with the following parameters: --no-unal --local --very-sensitive-local --nodiscordant --no-mixed --contain --overlap --dovetail --phred33. Approximate fragment size for paired end read data was determined from mapped bam files using CollectInsertSizeMetrics (Broad Institute, Picard). Bam files were visualized using DeepTools bamcoverage ([@bib43]) with a bin size of 1 to generate bigwig files. Data was viewed in IGV viewer and exported as EPS files. Cellular bigwig files were normalized for sequencing depth, the y-axes values are mapped reads per billion total reads. Viral bigwig files were further normalized per viral genome copy number, see Table 3C. The y-axes values are mapped reads per billion total reads per viral genome copy number. The normalized bigwig files were averaged between three biological replicates. Heatmaps and gene profiles were generated using MultiBigwigSummary ([@bib43]) on normalized cellular bigwig files to all UCSC annotated mRNAs. Gene profiles and heatmaps were plotted using plotProfile and plotHeatmap ([@bib43]). To calculate the percentage of total DNA corresponding to the virus or host in n12 and WT HSV-1 infection, we utilized ChIP-Seq input reads. We calculated the average percentage of total reads which mapped to either the virus or host in four biological replication ChIP-Seq samples. We used this value to calculate the number of viral genomes contained within each nucleus. This value was used to determine the tagmentation enrichment observed relative to the actual amount of genome content present.
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All data are publicly accessible in the SRA database (PRJNA553543, PRJNA553555, PRJNA553559, PRJNA553563, PRJNA508791).

The following datasets were generated:

SarahE DremelNealA DeLuca2019ICP4 ChIP-Seq of WT (KOS) HSV-1 Productive Infection in MRC5 cellsSequence Read ArchivePRJNA553563

SarahDremelNealDeLuca2019ATAC-Seq of WT (KOS) and ICP4 null (n12) HSV-1 Productive Infection in MRC5 cellsSequence Read ArchivePRJNA553559

SarahDremelNealDeLuca2019GTF ChIP-Seq of WT (KOS) and ICP4 null (n12) HSV-1 Productive Infection in MRC5 cellsSequence Read ArchivePRJNA553555

SarahE DremelNealA DeLuca2019Histone ChIP-Seq of WT (KOS) and ICP4 null (n12) HSV-1 Productive Infection in MRC5 cellsSequence Read ArchivePRJNA553543

The following previously published dataset was used:

SarahE DremelNealA DeLuca2019ChIP-Seq of HSV-1 (tsKos) Productive InfectionSequence Read ArchivePRJNA508791
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Herpes Simplex nucleoprotein creates a competitive environment facilitating robust viral transcription and host shut off\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Jessica Tyler as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Lars Dölken (Reviewer \#2).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The manuscript describes how the HSV-1 protein ICP4 plays a pivotal role in the reprogramming of the cellular Pol II transcription machinery. The authors show that the ICP4 preferentially binds to the viral genome and forms a viral nucleoprotein, which then preferentially recruits Pol II transcription factors to the viral genome, effectively causing the host-shut off. Apparently, ICP4 favorably binds to the incoming naked viral DNA at early times of infection. Overall, the paper describes a novel and important property of ICP4 protein in the life cycle of HSV. However, the reviewers raised a number of questions that should be addressed in the revised submission.

Essential revisions:

1\) In ICP4 null mutants, one can still observe relatively high read coverage for ICP4 binding (e. g. Figure 2---figure supplement 1, and others). How do the authors explain this pattern for ICP4 null mutant, where no ICP4 binding should be observed? If such a coverage represents non-specific background, the authors should explicitly state whether the background reads have been subtracted from the coverage graphs of ICP4 binding in all figures?

2\) The main conclusion of the authors is that ICP4 not only binds a specific motif at viral E promoters early in infection but promiscuously binds the incoming viral DNA. While the quantitative analysis strongly support their hypothesis, other explanations and particularly the implications of their finding should be considered and more thoroughly discussed. Of note, the effect of ICP4 on viral genome accessibility was rather small (2.8- vs. 4-fold). What is the advantage for the virus recruiting ICP4 in a sequence-independent manner to the viral genome? How does this contribute to differences in E and L promoters? The authors should expand their discussion on this.

3\) The authors state that ICP4 binding to the cellular genome is restricted to accessible regions of the cellular genome, namely the promoter regions. However, ICP4 is well known to bind to Mediator, which shows the same distribution pattern as ICP4 on cellular genes early in infection as ICP4. As specific ICP4 binding motifs do not explain the binding of ICP4 to cellular promoter regions, an alternative explanation is that ICP4 is recruited to cellular promoter regions via its interaction with Mediator (and not by its DNA-binding activity). ATAC-seq also reveals sites of the genome which become \"accessible\" independent of Mediator. The authors should check for co-localisation of ICP4-reads with ATAC-seq peaks outside of promoter regions (with no overlapping Mediator reads).

4\) The antibodies section of the Materials and methods should indicate that the Pol II antibody is specific for phosphorylated Serine 5 residues of the CTD. The use of the 4H8 clone of the Pol II antibody as a readout for total pol II occupancy should generally be avoided. While this clone is commonly used to measure global pol II occupancy, phospho-Serine 5 is enriched compared to total pol II at promoters and splice sites. This bias, if anything, was likely beneficial to the authors as they focus the most on promoters, though it may preclude more in-depth analysis in the future in regards to other steps of transcription or under experimental conditions in which Serine 5 phosphorylation is altered. Thus, it is important for this bias (stated on the manufacturer\'s website) to be apparent at-a-glance to the reader.

5\) The authors adapted the y-axis scale in a number of figures to provide a better visualization of their data. While this was done well for most figures, some of the scale adjustments make it hard to compare results. For example in Figure 2B, the authors show the occupancy of polII, TBP aso. on two selected virus genes. Unfortunately, the y-axis drastically vary between the panel, making a comparison very difficult (e.g. Sp1 32,312 vs. 11,877). These differences make it also hard to compare the n12 mutant and wild type virus in Figure 3---figure supplement 3. The authors should standardize the y-axis scales to allow the comparison between panels and to avoid miss-interpretations.

6\) Subsection "ICP4 as both viral transcription factor and chromatin": It is currently unclear whether the recruitment of major IE transcription factors to the incoming viral genomes only occurs in HSV infection or also in other herpesviruses, e.g. CMV infection. Therefore, there is currently no evidence that this explains differences in the kinetics of lytic replication between different herpesviruses. Interestingly, the relative contribution of viral gene expression during the first 2h of MCMV infection is even higher than observed for HSV-1. However, MCMV DNA replication does not start until 12 h p.i. whereas it initiates already at 2 h p.i. in HSV-1 infection. Two hours of interferon treatment are not sufficient to induce a strong protective antiviral state. Therefore, host responses are unlikely to prevent viral DNA replication in MCMV infection from already initiating at 2 h p.i. Combined, this strongly argues against a prominent role of the recruitment of ICP4 to viral genomes in explaining the differences in replication kinetics between different herpesviruses. Considering the conserved IE, E, L gene expression cascade, one might assume that coating of the incoming viral genomes with the major viral transactivator is a conserved feature of herpesviruses.

10.7554/eLife.51109.028

Author response

> Essential revisions:
>
> 1\) In ICP4 null mutants, one can still observe relatively high read coverage for ICP4 binding (e. g. Figure 2---figure supplement 1, and others). How do the authors explain this pattern for ICP4 null mutant, where no ICP4 binding should be observed?

ICP4 is packaged into the viral tegument and thus enters the cell with the infecting virion. In order to produce stocks of ICP4 null virus, we must grow the virus in complementing cells which produce ICP4. Thus, n12 still has ICP4 packaged into the virions, but does not produce any nascent ICP4 during infection. We cannot say whether the reads we see with ICP4 ChIP-seq of n12 infection are due to incoming tegument ICP4 binding the viral genome, or ICP4 bringing viral genome fragments into the tegument during virion production in the complementing cells. To clarify this fact for the readers we have added the following to the text:

"There were a relatively small number of reads in the ICP4 ChIP of n12 (Figure 2A, Figure 2---figure supplement 1). \[...\] While the ultimate source of these reads is not clear at present, the amount of binding of ICP4 from the virion to DNA is not sufficient to promote transcription complexes on viral early and late genes."

> If such a coverage represents non-specific background, the authors should explicitly state whether the background reads have been subtracted from the coverage graphs of ICP4 binding in all figures?

We did not subtract input or background reads from any of our ChIP-seq data. The data has been multiplied by a set factor in order to adjust for sequencing depth and viral genome copy number (see additional details in the Materials and methods section).

> 2\) The main conclusion of the authors is that ICP4 not only binds a specific motif at viral E promoters early in infection but promiscuously binds the incoming viral DNA. While the quantitative analysis strongly support their hypothesis, other explanations and particularly the implications of their finding should be considered and more thoroughly discussed. Of note, the effect of ICP4 on viral genome accessibility was rather small (2.8- vs. 4-fold).

We have added a panel to Figure 3 to demonstrate that there is no difference in nucleosome occupancy in the absence of ICP4. Additionally, we repeated the ATAC-Seq experiment with two additional biological replicates, which confirmed the original data. We have now adjusted Figure 3 to include all the biological replicates. The calculations in Table 3C has been adjusted to include the new data. We now observe that n12 and WT virus have a tagmentation enrichment of 2.2 and 2-fold, respectively.

> What is the advantage for the virus recruiting ICP4 in a sequence-independent manner to the viral genome? How does this contribute to differences in E and L promoters? The authors should expand their discussion on this.

The following has been added:

"Our observation that ICP4 coats the viral genome, a unique recruitment phenotype for a protein that functions in GTF recruitment likely reflects the architecture of the viral genome. \[...\] It is also possible that the relatively high density of ICP4 on the viral genome prior to DNA replication may serve to repress transcription of the true late promoters, which only contain binding sites for the core GTFs. It has been shown that ICP4 binding can impose an increased dependence on DNA replication for expression from relatively simple promoters (Koop et al., 1993; Rivera-Gonzalez et al., 1994)."

> 3\) The authors state that ICP4 binding to the cellular genome is restricted to accessible regions of the cellular genome, namely the promoter regions. However, ICP4 is well known to bind to Mediator, which shows the same distribution pattern as ICP4 on cellular genes early in infection as ICP4. As specific ICP4 binding motifs do not explain the binding of ICP4 to cellular promoter regions, an alternative explanation is that ICP4 is recruited to cellular promoter regions via its interaction with Mediator (and not by its DNA-binding activity).

We agree that ICP4 may be stabilized in binding to cellular promoters via it's well known interactions with Mediator and TFIID components. However, this does not detract from ICP4's ability to directly bind dsDNA which has been well established in vivo and in vitro. We have added the following:

"Furthermore, we found that ICP4 specifically bound where there was an absence of histones, adjacent to euchromatic markers. \[...\] The GTF's present on these cellular promoters, namely TFIID and Mediator complex, may further stabilize ICP4 binding at these promoters via their well-characterized interactions (Carrozza and DeLuca, 1996; Lester and Deluca; Wagner and DeLuca, 2013)."

> ATAC-seq also reveals sites of the genome which become \"accessible\" independent of Mediator. The authors should check for co-localisation of ICP4-reads with ATAC-seq peaks outside of promoter regions (with no overlapping Mediator reads).

We realized that Figure 5---figure supplement 2 was not included in the PDF sent to reviewers, we have corrected this. In Figure 5---figure supplement 2 we show that ICP4 peaks were primarily localized (\>80%) within 1 kilobase of mRNA promoters, referenced in the subsection "ICP4 binding is restricted to accessible regions of the cellular genome". For this reason, we limited our analyses within the paper to promoter regions.

> 4\) The antibodies section of the Materials and methods should indicate that the Pol II antibody is specific for phosphorylated Serine 5 residues of the CTD. The use of the 4H8 clone of the Pol II antibody as a readout for total pol II occupancy should generally be avoided. While this clone is commonly used to measure global pol II occupancy, phospho-Serine 5 is enriched compared to total pol II at promoters and splice sites. This bias, if anything, was likely beneficial to the authors as they focus the most on promoters, though it may preclude more in-depth analysis in the future in regards to other steps of transcription or under experimental conditions in which Serine 5 phosphorylation is altered. Thus, it is important for this bias (stated on the manufacturer\'s website) to be apparent at-a-glance to the reader.

We have added the following:

"In all Pol II IP's we used an antibody which preferentially binds to phospho S5 of the C-terminal domain repeat region. This post-translational modification is associated with Pol II found on mRNA promoters and splice sites."

"specific to phospho S5 of the C-terminal domain repeat region"

> 5\) The authors adapted the y-axis scale in a number of figures to provide a better visualization of their data. While this was done well for most figures, some of the scale adjustments make it hard to compare results. For example in Figure 2B, the authors show the occupancy of polII, TBP aso. on two selected virus genes. Unfortunately, the y-axis drastically vary between the panel, making a comparison very difficult (e.g. Sp1 32,312 vs. 11,877). These differences make it also hard to compare the n12 mutant and wild type virus in Figure 3---figure supplement 3. The authors should standardize the y-axis scales to allow the comparison between panels and to avoid miss-interpretations.

Figure 2B, and Figure 3---figure supplement 3A have been adjusted so that the y-axes for each IP are the same across panels.

> 6\) Subsection "ICP4 as both viral transcription factor and chromatin": It is currently unclear whether the recruitment of major IE transcription factors to the incoming viral genomes only occurs in HSV infection or also in other herpesviruses, e.g. CMV infection. Therefore, there is currently no evidence that this explains differences in the kinetics of lytic replication between different herpesviruses. Interestingly, the relative contribution of viral gene expression during the first 2h of MCMV infection is even higher than observed for HSV-1. However, MCMV DNA replication does not start until 12 h p.i. whereas it initiates already at 2 h p.i. in HSV-1 infection. Two hours of interferon treatment are not sufficient to induce a strong protective antiviral state. Therefore, host responses are unlikely to prevent viral DNA replication in MCMV infection from already initiating at 2 h p.i. Combined, this strongly argues against a prominent role of the recruitment of ICP4 to viral genomes in explaining the differences in replication kinetics between different herpesviruses. Considering the conserved IE, E, L gene expression cascade, one might assume that coating of the incoming viral genomes with the major viral transactivator is a conserved feature of herpesviruses.

We have deleted the sentence pertaining to this at the end of the Discussion.
